Clinical Trials Results - National Cancer Institute

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -7 of 7 Show results per page	View Search Criteria \| Help With Results

Last Modified: 8/12/2003 First Published: 11/24/2002


1.		Phase II Randomized Pilot Study of Sequential Vaccinia-CEA-TRICOM Vaccine, Fowlpox-CEA-TRICOM Vaccine, and Sargramostim (GM-CSF) With Standard Adjuvant Chemotherapy in Women With High-Risk Stage II or III Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				NCI-03-C-0005 NCI-5191, 5191, NCT00052351

Last Modified: 7/1/2002 First Published: 2/1/2001


2.		Phase I Study of Recombinant Fowlpox-CEA-TRICOM Vaccine Alone or in Combination With Recombinant Vaccinia-CEA-TRICOM Vaccine With or Without Sargramostim (GM-CSF) in Patients With CEA-Expressing Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				NCI				GUMC-00101 GUMC-IBC20-09, NIH/OBA-0006-405, NCI-833, NCT00009958, 833

Last Modified: 4/20/2007 First Published: 12/1/2001


3.		Phase I Study of Active Immunotherapy Comprising Autologous Dendritic Cells Infected With Recombinant Fowlpox-CEA-TRICOM Vaccine in Patients With Advanced or Metastatic Malignancies Expressing CEA

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over				NCI				DUMC-2840-02-6R1 NCI-1864, NCT00027534, 1864

Last Modified: 4/20/2007 First Published: 1/1/2002


4.		Phase I Study of Recombinant Fowlpox-CEA-TRICOM Vaccine With or Without Sargramostim (GM-CSF) or Recombinant Fowlpox-GM-CSF in Patients With Advanced or Metastatic CEA-Expressing Adenocarcinomas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over				NCI				FCCC-01016 NCI-1133, NCT00028496, 1133

Last Modified: 4/2/2008 First Published: 8/5/2005


5.		Phase I Study Denileukin Diftitox Followed by Active Immunotherapy Comprising Autologous Dendritic Cells Infected With Recombinant Fowlpox-CEA(6D)-TRICOM Vaccine in Patients With Metastatic CEA-Expressing Malignancies

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				NCI				DUMC-NCI-7042 7042, NCI-7042, NCT00128622

Last Modified: 10/10/2008 First Published: 5/28/2004


6.		Pilot Study of Vaccinia-CEA-TRICOM Vaccine, Fowlpox-CEA-TRICOM Vaccine, Recombinant Fowlpox GM-CSF Vaccine, and Radiotherapy in Patients With Carcinoembryonic Antigen-Positive Solid Tumors Metastatic to the Liver

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Treatment				Closed				18 and over				NCI				NCI-04-C-0167 6368, NCI-6368, NCT00085241

Last Modified: 10/10/2008 First Published: 8/24/2004


7.		Pilot Study of Vaccinia-CEA-TRICOM Vaccine, Fowlpox-CEA-TRICOM Vaccine, and Recombinant Fowlpox GM-CSF Vaccine With Paclitaxel, Carboplatin, and Radiotherapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Treatment				Completed				18 and over				NCI				NCI-04-C-0252 NCI-6439, 6439, NCT00091039

Select All on One Page